Als Ltd. · ASX:ALQ

Als — FY2012 Earnings Presentation

19 slides from Als's earnings presentation, May 2012

  1. Slide 1: 2012 Full Year Results Presentation

    2012 FULL YEAR Results Presentation Investor Road Show May 2012

  2. Slide 2: Important Notice and Disclaimer

    IMPORTANT NOTICE AND DISCLAIMER • This presentation has been prepared by Campbell Brothers Limited, (CBL or the Company). It contains general information about the Company’s activities as at the date of the presentation. It is information given in summary form and does not purport to be complete. Th

  3. Slide 3: March 2012 Full Year Snapshot

    March 2012 Full Year Snapshot pre unusual items FY08 FY09 REVENUE FY10 31st March 2012 27 FY11 % FY12 $1406mn 0 250 500 750 1000 1250 1500 FY08 FY09 EBITDA 31st March 2012 FY10 57 FY11 % FY12 $374mn 0 60 120 180 240 300 360 FY08 FY09 NPAT 31st March 2012 FY10 68 FY11 % FY12 $222mn 0 40 80 120 160 20

  4. Slide 4: Full Year Results – Overview

    Full Year Results – Overview excluding unusual items Mar 12 Mar 11 Change Revenue ($mn) 1,406 1,108 +27% EBITDA ($mn) 374 238 +57% Profit before tax ($mn) 312 186 +68% Net profit after tax ($mn) 222.4 132.2 +68% Wtd. ave. number of shares 67,503,000 65,139,000 +4% Earnings per share (c) 329 203 +62%

  5. Slide 5: Maintaining Dividend Growth

    Maintenance of Dividend Policy $0.00 $0.20 $0.40 $0.60 $0.80 $1.00 $1.20 $1.40 $1.60 $1.80 $2.00 $2.20 $2.40 2003 Maintaining Dividend Growth 2004 Year End March 2005 2006 2007 2008 2009 2010 2011 2012 Total dividend $2.25 - 68% payout ratio 5

  6. Slide 6: Total Shareholder Return

    Total Shareholder Return – last three year period Campbell Brothers Boart Longyear Core Laboratories Monadelphous Cardno Intertek Bureau Veritas MacMahon Orica Eurofins Clough Worley Parsons Ausenco SGS Transfield Services Servcorp Coffey -100% 0% 100% 200% 300% 400% 500% 600% 700% Total Shareholder

  7. Slide 7: ALS - New Divisional Structure

    ALS - New Divisional Structure - Four Global Divisions - Ten Business Streams 13% 7% 49% 31% Revenue by Division 7

  8. Slide 8: ALS Group Full Year Snapshot

    ALS Group Full Year Snapshot Average USD:AUD (cents) REVENUE 88 79 86 95 105 31st March 2012 39 1200 400 % $1192mn 350 1000 EBITDA & EBIT (AUD million) Revenue (AUD million) 300 800 250 EBITDA 31st March 2012 54 600 200 % $385mn 150 400 100 200 50 EBIT 31st March 2012 61 0 0 % FY08 FY09 FY10 FY11 FY

  9. Slide 9: Growth of non-Minerals Divisions

    Growth of non-Minerals Divisions Revenue EBITDA (incl ALS overheads) 1,400 400 Non-Mineral EBITDA margin 21% 21% 24% 20% 24% 23% 25% 1,200 350 300 1,000 AUD$ millions AUD$ millions 250 800 200 600 150 400 100 200 50 - - FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY06 FY07 FY08 FY09 FY10 FY11 FY12 Life Scien

  10. Slide 10: ALS Group Revenue Performance

    ALS Group Revenue Performance Revenue by Geography FY11 Vs FY12 9% Reported Growth 39% 6% 7% 1400 5% 5% 5% Australia 1200 Asia 44% 46% ALS Revenue AUD $million Nth America 1000 Sth America 32% Africa 800 32% 5% Europe Constant Currency Growth 46% 4% 600 400 Revenue by Division 200 FY11 Vs FY12 0 13%

  11. Slide 11: ALS Group Performance

    ALS Group Performance EBIT Margin (incl. ALS overheads) 40% 35% 30% 25% 20% FY2011 15% FY2012 10% 5% 0% Minerals Life Sciences Energy Industrial Revenue Growth Industrial Energy Life Sciences Minerals -20% -10% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% Organic Acquired FX Impact 11

  12. Slide 12: Minerals Division

    Minerals Division Overview 2012 2011 Change • Acquisition (AUD$222mn) and integration of Stewart Group very successful Revenue $591mn $334mn 77% • 16 new or refurbished laboratories completed EBITDA $234mn $127mn 84% • Successful introduction of CoreViewerTM • Expansion in central Asia EBIT $215mn $

  13. Slide 13: Life Sciences Division

    Life Sciences Division 2012 2011 Change Overview Revenue $361mn $308mn 17% • Acquisition (AUD$40mn) and integration of Columbia Analytical Services very successful EBITDA $96mn $82mn 17% • Acquisition (AUD$40mn) of Eclipse and AMS EBIT $78mn $66mn 18% completed in April 2012 EBIT Margin 21.7% 21.5%

  14. Slide 14: Energy Division

    Energy Division Overview 2012 2011 Change • Excellent year, far exceeding industry growth rates Revenue $88mn $73mn 20% • Laboratory industry leading safety record; LTIFR = 2.4 EBITDA $26.6mn $19.9mn 34% • Full commissioning of the new Brisbane laboratory – EBIT $23.7mn $17.2mn 38% the largest coal

  15. Slide 15: Industrial Division

    Industrial Division Overview 2012 2011 Change • Strong year leverage off continuing improvement Revenue $153mn $142mn 8% from previous year • Disposal of PearlStreet Energy Services allows focus EBITDA $29.0mn $20.6mn 41% on Asset Care business EBIT $24.5mn $16.6mn 48% • Acquistion (AUD$40mn )of Pow

  16. Slide 16: Campbell Chemical Division

    Campbell Chemical Division Overview 2012 2011 Change • Record sales and operating profit for the Panamex Group Revenue $90mn $130mn (31)% • Revenue down as a result of Cleantec disposal EBITDA $8.8mn $9.8mn (10)% • Strong sales in Papua New Guinea • Better cost control across all business sites EBIT

  17. Slide 17: Reward Distribution Division

    Reward Distribution Division Overview 2012 2011 Change • Significant turnaround from previous year • Excluding discontinued New Zealand operations, Revenue $123mn $124mn (0.6)% revenue up 3.8% in Australia on previous year EBITDA $4.5mn ($0.6)mn N.A. • Reduction in inventory • Disposal of underperfo

  18. Slide 18: Organic Investment Paying Off

    Organic Investment Paying Off Return on Equity CAPEX (AUD$mn) 28% 83 25% 72 71 23% 18% 50 14% 43 FY2008 FY2009 FY2010 FY2011 FY2012 FY2008 FY2009 FY2010 FY2011 FY2012 18

  19. Slide 19: Funding Strength

    Funding Strength Debt Maturity Profile 200 76 Bank Bank Capacity USPP 160 AUD $million 135 120 123 116 80 92 40 29 0 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Year Note: Gearing defined as Net Debt as a percentage of Net Debt plus Equity was 28% at the 31 st March 2012 19

ALS — FY2012 Earnings Presentation on 6ix